All the cases examined could be classified as: ErbB3: c-MET co-over-expression colorectal cancer, ErbB3:ErbB2 co-over-expression colorectal cancer, and ErbB3:ErbB2: c-MET co-over-expression colorectal cancer (Figure 2C). This evidence concerns the gene ERBB2 and colorectal cancer.